BACKGROUND AND AIMS: It is not clear whether alterations in the intestinal microbiota of children with celiac disease (CD) cause the disease or are a result of disease and/or its treatment with a gluten-free diet (GFD). METHODS: We obtained 167 fecal samples from 141 children (20 with new-onset CD, 45 treated with a GFD, 57 healthy children, and 19 unaffected siblings of children with CD) in Glasgow, Scotland. Samples were analyzed by 16S ribosomal RNA sequencing, and diet-related metabolites were measured by gas chromatography. We obtained fecal samples from 13 children with new-onset CD after 6 and 12 months on a GFD. Relationships between microbiota with diet composition, gastrointestinal function, and biomarkers of GFD compliance were explored. RESULTS: Microbiota α diversity did not differ among groups. Microbial dysbiosis was not observed in children with new-onset CD. In contrast, 2.8% (Bray-Curtis dissimilarity index, P = .025) and 2.5% (UniFrac distances, P = .027) of the variation in microbiota composition could be explained by the GFD. Between 3% and 5% of all taxa differed among all group comparisons. Eleven distinctive operational taxonomic units composed a microbe signature specific to CD with high diagnostic probability. Most operational taxonomic units that differed between patients on a GFD with new-onset CD vs healthy children were associated with nutrient and food group intake (from 75% to 94%) and with biomarkers of gluten ingestion. Fecal levels of butyrate and ammonia decreased during the GFD. CONCLUSIONS: Although several alterations in the intestinal microbiota of children with established CD appear to be effects of a GFD, specific bacteria were found to be distinct biomarkers of CD. Studies are needed to determine whether these bacteria contribute to pathogenesis of CD.
BACKGROUND AND AIMS: It is not clear whether alterations in the intestinal microbiota of children with celiac disease (CD) cause the disease or are a result of disease and/or its treatment with a gluten-free diet (GFD). METHODS: We obtained 167 fecal samples from 141 children (20 with new-onset CD, 45 treated with a GFD, 57 healthy children, and 19 unaffected siblings of children with CD) in Glasgow, Scotland. Samples were analyzed by 16S ribosomal RNA sequencing, and diet-related metabolites were measured by gas chromatography. We obtained fecal samples from 13 children with new-onset CD after 6 and 12 months on a GFD. Relationships between microbiota with diet composition, gastrointestinal function, and biomarkers of GFD compliance were explored. RESULTS: Microbiota α diversity did not differ among groups. Microbial dysbiosis was not observed in children with new-onset CD. In contrast, 2.8% (Bray-Curtis dissimilarity index, P = .025) and 2.5% (UniFrac distances, P = .027) of the variation in microbiota composition could be explained by the GFD. Between 3% and 5% of all taxa differed among all group comparisons. Eleven distinctive operational taxonomic units composed a microbe signature specific to CD with high diagnostic probability. Most operational taxonomic units that differed between patients on a GFD with new-onset CD vs healthy children were associated with nutrient and food group intake (from 75% to 94%) and with biomarkers of gluten ingestion. Fecal levels of butyrate and ammonia decreased during the GFD. CONCLUSIONS: Although several alterations in the intestinal microbiota of children with established CD appear to be effects of a GFD, specific bacteria were found to be distinct biomarkers of CD. Studies are needed to determine whether these bacteria contribute to pathogenesis of CD.
Authors: Maria I Pinto-Sánchez; Edgardo C Smecuol; Maria P Temprano; Emilia Sugai; Andrea González; María L Moreno; Xianxi Huang; Premysl Bercik; Ana Cabanne; Horacio Vázquez; Sonia Niveloni; Roberto Mazure; Eduardo Mauriño; Elena F Verdú; Julio C Bai Journal: J Clin Gastroenterol Date: 2017-10 Impact factor: 3.062
Authors: David Kevans; Williams Turpin; Karen Madsen; Jon Meddings; Konstantin Shestopaloff; Wei Xu; Gabriel Moreno-Hagelsieb; Anne Griffiths; Mark S Silverberg; Andrew Paterson; Kenneth Croitoru Journal: Inflamm Bowel Dis Date: 2015-04 Impact factor: 5.325
Authors: Alberto Caminero; Alexandra R Herrán; Esther Nistal; Jenifer Pérez-Andrés; Luis Vaquero; Santiago Vivas; José María G Ruiz de Morales; Silvia M Albillos; Javier Casqueiro Journal: FEMS Microbiol Ecol Date: 2014-03-03 Impact factor: 4.194
Authors: Andre P Masella; Andrea K Bartram; Jakub M Truszkowski; Daniel G Brown; Josh D Neufeld Journal: BMC Bioinformatics Date: 2012-02-14 Impact factor: 3.169
Authors: Christian R Kahrs; Katerina Chuda; German Tapia; Lars C Stene; Karl Mårild; Trond Rasmussen; Kjersti S Rønningen; Knut E A Lundin; Lenka Kramna; Ondrej Cinek; Ketil Størdal Journal: BMJ Date: 2019-02-13
Authors: Christopher Quince; Umer Zeeshan Ijaz; Nick Loman; A Murat Eren; Delphine Saulnier; Julie Russell; Sarah J Haig; Szymon T Calus; Joshua Quick; Andrew Barclay; Martin Bertz; Michael Blaut; Richard Hansen; Paraic McGrogan; Richard K Russell; Christine A Edwards; Konstantinos Gerasimidis Journal: Am J Gastroenterol Date: 2015-11-03 Impact factor: 10.864
Authors: Pernille Kihl; Lukasz Krych; Ling Deng; Lars H Hansen; Karsten Buschard; Søren Skov; Dennis S Nielsen; Axel Kornerup Hansen Journal: PLoS One Date: 2022-04-13 Impact factor: 3.240
Authors: Mirco Vacca; Annalisa Porrelli; Francesco Maria Calabrese; Tamara Lippolis; Ilaria Iacobellis; Giuseppe Celano; Daniela Pinto; Francesco Russo; Gianluigi Giannelli; Maria De Angelis Journal: Front Microbiol Date: 2022-06-23 Impact factor: 6.064
Authors: Iwona Kaliciak; Konstanty Drogowski; Aleksandra Garczyk; Stanisław Kopeć; Paulina Horwat; Paweł Bogdański; Marta Stelmach-Mardas; Marcin Mardas Journal: Nutrients Date: 2022-05-16 Impact factor: 6.706
Authors: Holly A Morrison; Yang Liu; Kristin Eden; Margaret A Nagai-Singer; Paul A Wade; Irving C Allen Journal: Front Immunol Date: 2022-04-28 Impact factor: 8.786
Authors: Yael R Nobel; Felix Rozenberg; Heekuk Park; Daniel E Freedberg; Martin J Blaser; Peter H R Green; Anne-Catrin Uhlemann; Benjamin Lebwohl Journal: Clin Transl Gastroenterol Date: 2021-12-20 Impact factor: 4.488
Authors: Maureen M Leonard; Francesco Valitutti; Hiren Karathia; Meritxell Pujolassos; Victoria Kenyon; Brian Fanelli; Jacopo Troisi; Poorani Subramanian; Stephanie Camhi; Angelo Colucci; Gloria Serena; Salvatore Cucchiara; Chiara Maria Trovato; Basilio Malamisura; Ruggiero Francavilla; Luca Elli; Nur A Hasan; Ali R Zomorrodi; Rita Colwell; Alessio Fasano Journal: Proc Natl Acad Sci U S A Date: 2021-07-20 Impact factor: 11.205